We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $646M
1-Year Est. Return 43.3%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+43.3%
3 Year Est. Return
+98.62%
5 Year Est. Return
+125.42%
10 Year Est. Return
+408.39%
AUM
$236M
AUM Growth
+$11.3M
Cap. Flow
+$2.4M
Cap. Flow %
1.02%
Top 10 Hldgs %
32.76%
Holding
119
New
6
Increased
45
Reduced
36
Closed
15

Top Buys

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$916K
2
ABT icon
Abbott
ABT
+$605K
3
ROK icon
Rockwell Automation
ROK
+$566K
4
XLNX
Xilinx Inc
XLNX
+$559K
5
TGT icon
Target
TGT
+$520K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$2.61M
2
ADP icon
Automatic Data Processing
ADP
+$553K
3
XOM icon
ExxonMobil
XOM
+$394K
4
DYAX
DYAX CORPORATION
DYAX
+$376K
5
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$354K

Sector Composition

Rank Sector Weight
1 Technology 21.07%
2 Healthcare 20.68%
3 Industrials 19.38%
4 Energy 10.99%
5 Consumer Staples 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLB icon
26
SLB Ltd
SLB
$77.3B
$3.11M 1.32%
36,382
+1,571
+5% +$145K
JCI icon
27
Johnson Controls International
JCI
$91.7B
$3.07M 1.3%
60,728
+4,307
+8% +$210K
PBA icon
28
Pembina Pipeline
PBA
$28.4B
$2.98M 1.26%
81,755
-1,195
-1% -$45.3K
CSCO icon
29
Cisco
CSCO
$447B
$2.83M 1.2%
101,712
+3,910
+4% +$101K
GE icon
30
GE Aerospace
GE
$374B
$2.61M 1.11%
21,556
+105
+0.5% +$12.9K
DE icon
31
Deere & Co
DE
$165B
$2.54M 1.07%
28,672
-2,328
-8% -$201K
XLNX
32
DELISTED
Xilinx Inc
XLNX
$2.51M 1.06%
58,015
+12,915
+29% +$559K
IRWD icon
33
Ironwood Pharmaceuticals
IRWD
$674M
$2.49M 1.05%
193,840
-4,776
-2% -$54.7K
MON
34
DELISTED
Monsanto Co
MON
$2.4M 1.02%
20,087
+3,155
+19% +$366K
PRGO icon
35
Perrigo
PRGO
$1.76B
$2.32M 0.98%
13,905
+140
+1% +$21.9K
UNP icon
36
Union Pacific
UNP
$174B
$2.3M 0.98%
19,334
+1,266
+7% +$145K
TGT icon
37
Target
TGT
$70.6B
$2.26M 0.96%
29,750
+7,710
+35% +$520K
MSFT icon
38
Microsoft
MSFT
$3.69T
$2.19M 0.93%
47,117
+1,303
+3% +$61.2K
ABBV icon
39
AbbVie
ABBV
$443B
$2.03M 0.86%
31,090
+2,020
+7% +$127K
SPTM icon
40
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
$1.96M 0.83%
75,918
-2,082
-3% -$52.2K
MRK icon
41
Merck
MRK
$334B
$1.82M 0.77%
33,691
+792
+2% +$44.1K
IPGP icon
42
IPG Photonics
IPGP
$3.57B
$1.79M 0.76%
23,875
+1,960
+9% +$139K
HON icon
43
Honeywell
HON
$74.2B
$1.72M 0.73%
19,191
– –
SIAL
44
DELISTED
SIGMA - ALDRICH CORP
SIAL
$1.63M 0.69%
11,860
– –
XYL icon
45
Xylem
XYL
$28.1B
$1.62M 0.69%
42,630
+13,685
+47% +$501K
VFC icon
46
VF Corp
VFC
$5.79B
$1.53M 0.65%
21,771
-1,848
-8% -$122K
BMY icon
47
Bristol-Myers Squibb
BMY
$132B
$1.45M 0.62%
24,600
-156
-0.6% -$8.8K
DD
48
DELISTED
Du Pont De Nemours E I
DD
$1.4M 0.59%
19,938
– –
ABB
49
DELISTED
ABB Ltd
ABB
$1.21M 0.51%
57,161
-15,880
-22% -$344K
KO icon
50
Coca-Cola
KO
$376B
$1.1M 0.47%
26,015
-412
-2% -$17.6K
1
2
3 4 5

Similar funds

HCM
Huber Capital Management El Segundo, California $647M AUM 24.91% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
CRCM
Cat Rock Capital Management Greenwich, Connecticut $644M AUM 1.97% 1-Year Est. Return
GECH
Garnet Equity Capital Holdings New York $642M AUM 58.94% 1-Year Est. Return
APC
Alta Park Capital San Francisco, California $642M AUM 140.04% 1-Year Est. Return
WHGAM
Wealth High Governance Asset Management Sao Paulo $641M AUM
AG
Alibaba Group Causeway Bay, Hong Kong $653M AUM 16.11% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Brian C. Broderick's Q4 2014 Portfolio in Review

As of Q4 2014, Brian C. Broderick held 119 positions worth $236M, up 5% from $225M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Brian C. Broderick's Q4 2014 filing shows 6 new, 45 increased, 36 reduced and 15 closed positions. Its largest new stake was CDK Global, Inc.: 25,869 shares worth $1.05M. The largest sale was GSK, an estimated $2.61M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Brian C. Broderick's largest Q4 2014 buy was CDK Global, Inc.: 25,869 shares worth $1.05M.
  • Brian C. Broderick added most to Abbott in Q4 2014, an estimated $605K increase.
  • Brian C. Broderick's biggest Q4 2014 reduction was GSK, cutting an estimated $2.61M.
  • Brian C. Broderick fully exited Vanguard FTSE Emerging Markets ETF in Q4 2014, selling an estimated $354K.
  • Brian C. Broderick's ten largest holdings make up 33% of its $236M portfolio in Q4 2014.
  • Brian C. Broderick opened 6 new positions and closed 15 in Q4 2014.
  • Brian C. Broderick's portfolio value rose 5% quarter-over-quarter to $236M.

Based on Brian C. Broderick's 13F filing for Q4 2014, filed 13 Feb 2015.